Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Treasury Shares (2021 - 2026)

PROCEPT BioRobotics has reported Treasury Shares over the past 6 years, most recently at $314000.0 for Q1 2026.

  • Quarterly Treasury Shares rose 129.2% to $314000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $314000.0 through Mar 2026, up 129.2% year-over-year, with the annual reading at $2.3 million for FY2025, 2796.3% up from the prior year.
  • Treasury Shares was $314000.0 for Q1 2026 at PROCEPT BioRobotics, down from $2.3 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $2.3 million in Q4 2025 and troughed at $81000.0 in Q4 2024.
  • The 5-year median for Treasury Shares is $1.5 million (2023), against an average of $1.2 million.
  • Year-over-year, Treasury Shares plummeted 94.82% in 2024 and then surged 2796.3% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $742000.0 in 2022, then skyrocketed by 110.92% to $1.6 million in 2023, then plummeted by 94.82% to $81000.0 in 2024, then surged by 2796.3% to $2.3 million in 2025, then tumbled by 86.62% to $314000.0 in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Treasury Shares are $314000.0 (Q1 2026), $2.3 million (Q4 2025), and $2.2 million (Q3 2025).